Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
559
-
Total 13F shares, excl. options
-
87.9M
-
Shares change
-
+2.69M
-
Total reported value, excl. options
-
$12.5B
-
Value change
-
+$382M
-
Put/Call ratio
-
0.27
-
Number of buys
-
257
-
Number of sells
-
-253
-
Price
-
$142.17
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2015
647 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q3 2015.
Edwards Lifesciences Corp - Common Stock (EW) has 559 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.9M shares
of 590M outstanding shares and own 14.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.03M shares), WELLINGTON MANAGEMENT GROUP LLP (4.34M shares), Capital Research Global Investors (4.16M shares), BlackRock Institutional Trust Company, N.A. (2.96M shares), FMR LLC (2.73M shares), CITADEL ADVISORS LLC (2.22M shares), AQR CAPITAL MANAGEMENT LLC (2.11M shares), Winslow Capital Management, LLC (2.06M shares), BlackRock Fund Advisors (1.9M shares), and Voya Investment Management LLC (1.76M shares).
This table shows the top 559 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.